1. Academic Validation
  2. Functional characterization of the neuron-restrictive silencer element in the human tryptophan hydroxylase 2 gene expression

Functional characterization of the neuron-restrictive silencer element in the human tryptophan hydroxylase 2 gene expression

  • J Neurochem. 2017 Sep;142(6):827-840. doi: 10.1111/jnc.14060.
Yukino Nawa 1 Hanae Kaneko 1 Masayuki Oda 2 Masaaki Tsubonoya 1 Tomoko Hiroi 1 Maria Teresa Gentile 3 Luca Colucci-D'Amato 3 Ryoya Takahashi 4 Hiroaki Matsui 1 5
Affiliations

Affiliations

  • 1 Institute of Radioisotope Research, St. Marianna University Graduate School of Medicine, Kawasaki, Japan.
  • 2 Department of Pharmacogenomics, St. Marianna University Graduate School of Medicine, Kawasaki, Japan.
  • 3 Laboratory of Molecular and Cellular Pathology, Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, Second University of Naples, Caserta, Italy.
  • 4 Department of Biochemistry, Faculty of Pharmaceutical Sciences, Toho University, Funabashi, Japan.
  • 5 Department of Molecular and Behavioral Neuroscience, St. Marianna University Graduate School of Medicine, Kawasaki, Japan.
Abstract

Tryptophan Hydroxylase 2 (TPH2) is the key Enzyme in the synthesis of neuronal serotonin. Although previous studies suggest that TPH2 neuron-restrictive silencer element (NRSE) functions as a negative regulator dependent on neuron-restrictive silencer factor (NRSF) activity, the underlying mechanisms are yet to be fully elucidated. Here, we show a detailed analysis of the NRSE-mediated repression of the human TPH2 (hTPH2) promoter activity in RN46A cells, a cell line derived from rat raphe neurons. Quantitative real-time RT-PCR analysis revealed the expression of serotonergic marker genes (Mash1, Nkx2.2, Gata2, Gata3, Lmx1b, Pet-1, 5-Htt, and Vmat2) and Nrsf gene in RN46A cells. Tph1 mRNA is the prevalent form expressed in RN46A cells; Tph2 mRNA is also expressed but at a lower level. Electrophoretic mobility shift assays and reporter assays showed that hTPH2 NRSE is necessary for the efficient DNA binding of NRSF and for the NRSF-dependent repression of the hTPH2 promoter activity. The hTPH2 promoter activity was increased by knockdown of NRSF, or over-expression of the engineered NRSF (a dominant-negative mutant or a DNA-binding domain and activation domain fusion protein). MS-275, a class I histone deacetylase (HDAC) inhibitor, was found to be more potent than MC-1568, a class II HDAC Inhibitor, in enhancing the hTPH2 promoter activity. Furthermore, treatment with the Ubiquitin-Specific Protease 7 deubiquitinase inhibitors, P-22077 or HBX 41108, increased the hTPH2 promoter activity. Collectively, our data demonstrate that the hTPH2 NRSE-mediated promoter repression via NRSF involves class I HDACs and is modulated by the Ubiquitin-Specific Protease 7-mediated deubiquitination and stabilization of NRSF.

Keywords

NRSF; TPH2; gene expression; promoter; serotonergic neuron; transcriptional regulation.

Figures
Products